CANCER care in COVID-19 ERAâ?? A survey proposed to study the treatment preference and perspectives of patients with blood cancer in a highly specialized cancer care hospital in India during COVID-19 ERA.
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: C81-C96- Malignant neoplasms of lymphoid, hematopoietic and related tissue
- Registration Number
- CTRI/2020/06/026039
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients under evaluation for a suspected hematological malignancy or with a diagnosis of hematological malignancy (acute and chronic leukemias, lymphomas, myeloma, and others) will be included in the study.
2. Patients who are planned for or receiving chemotherapy / immunotherapy / targeted therapy in the OPD, ward, daycare and ICU will be eligible.
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of patients who plan to continue on full intensity therapy- This will be the percentage of patients who are willing to go ahead with the full intensity therapy in the current scenario.Timepoint: 6 months or till the end of pandemic
- Secondary Outcome Measures
Name Time Method